AlphaCrest Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-49,026	Closed	-$618K	–	132
2022 Q3	$618K	Buy	49,026 +32,405	+195%	+$408K	0.04%	883
2022 Q2	$176K	Buy	+16,621	New	+$176K	0.01%	1214